-+ 0.00%
-+ 0.00%
-+ 0.00%

Meiji Seika Pharma Receives Regulatory Approval in Japan for Two-Dose Vial of KOSTAIVE®, a Self-Amplifying mRNA COVID-19 Vaccine

Reuters·08/29/2025 10:10:48

Please log in to view news